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Abstract 
Free-running disorder (FRD) is characterized by inability to maintain stable entrainment to a 24h 
sleep-wake pattern. Patients with FRD show a sleep/wake pattern similar to those observed in time-
free environments bereft of zeitgebers.  
 
FRD is common in blind patients, and rarely occurs in sighted individuals. In individuals with no 
visual impairment, males are more commonly affected. Here, two unusual cases of FRD in young, 
sighted females are presented. Both patients responded to treatment with melatonin, but derived no 
perceived benefit from phototherapy. 
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Background 
 
 
Free-running disorder (FRD) or non-24h 
sleep/wake syndrome is characterized by an 
inability to maintain stable entrainment to a 
24h sleep/wake pattern, resulting in 
progressive delay of the sleep/wake period 
over time. This may impact on the 
individual’s ability to function within 24h 
societal constraints.  
 
In a research environment with all 
environmental time cues (zeitgebers) removed, 
the human circadian period is normally 
longer than 24h.1 Patients with FRD show a 
sleep/wake pattern similar to that observed 
in these time-free environments. Totally 
blind people with inability to perceive light, 
the most powerful zeitgeber, are commonly 
affected.2 The condition is rare in sighted 
individuals; therefore, much of the available 
evidence in patients with no visual 
impairment is based on case reports or small 
cohort studies.3 One large cohort study 
suggests that, in sighted individuals, FRD is 
much more common in males, with onset 
during the teenage years.2 
 
Here, we discuss two unusual presentations 
of FRD in young, sighted females. 
 
Case Report 
 
Case 1 
 
A 19-year-old female student was referred to 
the sleep clinic having failed the first year of 
her university studies due to sleeping in and 
missing lectures. 
  
She presented with a history of excessive 
daytime sleepiness (EDS) since secondary 
school, regularly sleeping through her 7 a.m. 
alarm. Though perceived to be due to poor 
motivation, she was, in fact, often awake 
until 4 a.m. She denied symptoms of sleep-
disordered breathing (SDB), such as snoring, 
witnessed apnoeas or choking episodes. 
There was no history of parasomnias, 
movements during sleep or symptoms of 
narcolepsy. She did not use tobacco, alcohol, 
caffeine or drugs. There was no family 
history of note, although she alluded to a 
“difficult childhood” and family expectation 
that she should be a high achiever. She had 
recently been diagnosed with depression, but 
was not on any medication. She had tried 
cognitive behavioural therapy, with limited 
success.  
 
On examination, she was overweight (BMI 
31.3 kg/m2). Her Epworth Sleepiness Score 
(ESS) was 12/24 – a score of >10 on this 
validated measure of subjective daytime 
sleepiness is indicative of excessive 
sleepiness.4 She had a Mallampati grade 2 
oropharynx; the Mallampati score grades the 
level of crowding of the oropharynx and has 
been shown to be of clinical value in 
assessment of SDB.5 Her sleep diary was 
consistent with a free-running circadian 
rhythm, her sleep phase delaying 
progressively over the 2-week period (Figure 
1). She had no regular bedtime or waking 
time, and was sleeping for 7–9h/night. 
Actigraphy (a non-invasive technique using a 
wrist-worn accelerometer to measure activity 
and non-activity as a proxy for sleep and 
wake) was not performed since the diary was 
completed in a satisfactory manner. 
 
Melatonin (2 mg) was prescribed for 
administration approximately 2h before her 
preferred bedtime, along with phototherapy 
at 7 a.m. On review in clinic after 7 weeks, 
she reported great benefit from melatonin,
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retiring at midnight, rising at 8 a.m. and 
sleeping for 7–8h/night. Her sleep/wake 
pattern was resetting well, and she perceived 
an overall improvement in her symptoms. 
She reported no benefit from phototherapy 
and discontinued from treatment. She was 
still depressed and was referred to 
psychology, continuing on melatonin. After 
12 months, her depression and FRD had 
corrected completely, with no further 
treatment required. 
 
CASE 2 
 
A 19-year-old woman presented with a 
history of “poor sleep” since birth. This was 
first investigated at age 14, at which time she 
was tired during the day with poor 
concentration and had missed much of her 
schooling. Her weight was normal (BMI 
22.6 kg/m2) and she did not exhibit 
symptoms of SDB or narcolepsy. 
Assessment by a clinical psychologist found 
no evidence of depression. She retired late, 
had difficulty initiating sleep, lay awake until 
4–5 a.m. and consequently slept late into the  
 
 
 
 
 
following day. Her sleep diary showed 
variable sleep duration of 1–16h sleep per 
day and a diagnosis of delayed sleep phase 
syndrome (DSPS) was made.  
 
The patient was investigated further at age 
15. By then, she was retiring at 5 a.m., falling 
asleep at 6 a.m. and waking refreshed at 4 
p.m. the following day. A 2-week actigraphy 
study showed a non-24h sleep/wake cycle. 
She was prescribed melatonin to take at 10 
p.m., with phototherapy in the morning. 
After 2 weeks, there was no improvement in 
her symptoms, perhaps due to incorrect use 
of the lightbox when awakening at 4 p.m.  
 
When seen in our clinic, the patient had 
passed all her school exams, albeit by sitting 
them at flexible times during the day and 
night. She was unemployed. She was slightly 
overweight (BMI 26.9 kg/m2) and did not 
report EDS (ESS 0/24). She had a 
Mallampati grade 1 oropharynx, with no 
symptoms of SDB, narcolepsy or 
parasomnias. She was an ex-smoker of 2 
months, having smoked 20 cigarettes/day 
since age 13 years. She drank only occasional  
Figure 1.  Sleep diary from Case 1 showing progressive delay of sleep period (black bars) over a 
2-week period. 
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alcohol and caffeine. She denied any 
hyperphagia, anorexia or hypersexuality. 
There was no mood disturbance. Her only 
medication was a progestogen-only oral 
contraceptive (OCP). Her mother had a 
history of discoid lupus and pernicious 
anaemia. There was no family history of 
sleep problems. Blood tests showed a 
vitamin B12 level at the lower end of normal, 
and low late-afternoon cortisol level. 
However, intrinsic factor antibody was 
normal, as was a short synacthen test. 
 
A 1-month actigraphy study confirmed a 
classical free-running circadian rhythm 
(Figure 2).  
 
 
 
 
 
 
The patient commenced 1 mg melatonin, to 
be taken 5h before bedtime while she was in 
a suitable day/night phase, along with oral 
B12 supplementation. Phototherapy was 
discontinued, with the intention of 
reinstating this once settled into a more 
regular rhythm. At a 5-month review, the 
patient was falling asleep around midnight 
and, although she was still sleeping until 
midday, there was now a consistent wake-
period during the daytime. Although still 
unemployed and lacking in daytime 
structure, she appeared more positive and 
committed to improving her sleep patterns. 
 
                             
Figure 2.  Actigraphy report (actogram) from Case 2. Note the aslant pattern, which is 
indicative of a classical free-running disorder.  
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Discussion 
 
Diagnostic criteria for FRD are outlined in 
the International Classification of Sleep Disorders 
2nd Edition (ICSD-2) as a primary complaint 
of either insomnia or excessive sleepiness 
related to abnormal synchronization 
between the external 24h light/dark cycle 
and internal circadian sleep/wake rhythm, 
which cannot be better explained by another 
sleep, medical, neurological or psychiatric 
disorder, or drug use.6  Although the absence 
of light perception is the cause in most blind 
subjects, the aetiology and pathogenesis of 
FRD in sighted individuals remains 
problematic; risk factors include cranial 
trauma,7 dementia8 and intellectual 
disability.8 Neither of our cases presented 
such a history. 
A previously published cohort of patients 
with FRD2 (n=57) suggests that, in sighted 
individuals, FRD is more common in males 
(male:female ratio 2.6:1) with age of onset 
typically during teenage years. Both of our 
cases experienced onset or worsening of 
symptoms in adolescence. DSPS 
(characterized by a consistent sleep schedule 
that is delayed beyond the conventionally 
desired time)7 and psychiatric problems 
preceded the symptoms of FRD in 26% and 
28% of the cohort respectively.2 Of the 
group exhibiting premorbid psychiatric 
problems 94% experienced secondary social 
withdrawal suggesting this to be an 
important aetiological factor in the 
pathogenesis of FRD. Nearly all patients 
(98%) experienced severely disrupted social 
functioning. This is reflected in our cases 
with both patients struggling to remain in 
education or employment. Patient 1 was 
depressed but it is possible that this was a 
result of, rather than a precursor to, the 
sleep disturbance with both her depression 
and FRD resolved by the use of melatonin. 
Patient 2 did not exhibit psychiatric 
problems but had been initially diagnosed 
with DSPS. 
Both ICSD-26 and practice parameters 
published by the American Academy of 
Sleep Medicine (AASM)10 recommend use of 
sleep diaries and/or actigraphy over multiple 
weeks for evaluation of FRD. AASM 
practice parameters support the 
measurement of circadian phase markers, 
e.g. melatonin rhythm, as an alternative 
diagnostic tool in cases where diary or 
actigraphy data are considered unreliable. 
However, we found this unnecessary since 
an adequate diagnosis was obtained using 
conventional methods. 
 
Recommended treatments for FRD include 
timed bright light exposure in the morning 
to increase the body’s production of 
endogenous melatonin, timed exogenous 
melatonin administration a few hours before 
bedtime, and prescribed sleep-wake 
scheduling.10 Both patients perceived benefit 
when using melatonin. Though neither 
found phototherapy useful, issues with 
correct use of the treatment were evident. 
Anecdotally, there is some evidence for the 
administration of vitamin B12 (oral or 
intramuscular) as a potential stimulus for 
entrainment, although the physiological basis 
for this is unclear. A multicentre trial of 
vitamin B12 for treatment of DSPS did not 
show any benefit.11 Patient 2 had a 
borderline low serum B12 level, possibly 
secondary to the OCP. 
 
It is important that interventions such as 
melatonin and phototherapy are reinforced 
by behavioural modifications and good sleep 
hygiene, such as maintaining a bedtime 
routine, creating a favourable sleeping 
environment and controlling light exposure. 
Patient 2 was particularly withdrawn and 
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isolated with no social cues to reinforce a 
24h rhythm.  
 
In conclusion, further research is required to 
better understand the aetiology and 
mechanisms of FRD in sighted patients. The 
link between psychiatric, behavioural and 
social factors as contributors and 
consequences of FRD is complex and merits 
investigation. However, the paucity of 
reported cases in this patient group presents 
a significant challenge. 
 
 
Key Learning Points 
 Free-running disorder (FRD) is common 
in people with visual impairments who 
lack light perception, but can occur, 
rarely, in the sighted. 
 
 Diagnostic criteria for FRD include a 
primary complaint of either insomnia or 
excessive sleepiness related to abnormal 
synchronisation between the external 
light/dark cycle and internal sleep/wake 
rhythm, which cannot be better explained 
by another disorder or drug use. 
 
 Recommended screening tools include 
actigraphy and/or sleep diaries over a 
number of weeks. 
 
 International guidelines recommend the 
use of melatonin and/or bright light 
therapy for treatment of FRD. However, 
correct administration and use is key to 
the success of these treatments, which 
should be reinforced  by behavioural 
modifications and good sleep hygiene. 
 
 Psychiatric, behavioural and social factors 
may be contributors to or consequences 
of FRD in the sighted, but further 
research is required to better understand 
the aetiology. 
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